Chemotherapy during pregnancy doesn't affect babies' health, IQ

09/26/2011 | Bloomberg

Full-term babies born to women undergoing chemotherapy treatments during pregnancy had normal general health, intelligence, hearing, growth and behavior at 18 months, a European study found. Meanwhile, children delivered intentionally premature so the mother could then begin the chemotherapy treatment were more likely to have lower-than-average IQ scores, researchers said. The results indicate that there is no need for pregnant women to delay chemotherapy until after childbirth, lead researcher Frederic Amant, of Belgium, said.

View Full Article in:

Bloomberg

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD